Of particular interest are TP53-mutated lymphoid malignancies (i.e. non-Hodgkin lymphoma and chronic lymphocytic leukemia), which lack the recurrent copy number losses observed in TP53-mutated myeloid malignancies. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.